 |
Quinine Powder Cinchona succirubra1 Pound (16 oz) Buy Now
|
|
Purchase a one pound package of Raintree's sustainably harvested pure quinine bark powder (Cinchona succirubra) - rich in active and beneficial phytochemicals that occur naturally in this plant. Quinine bark contains a alkaloid chemical also called quinine which has been turned into a antimalarial drug as well as used as a bitter agent in the manufacture of tonic waters and beverages.* This plant has been milled into a fine powder which is suitable to stuff into capsules or to prepare your own teas, tinctures or extracts. Raintree's quinine bark has been sustainably wild-harvested in the Brazilian Amazon (without any pesticides or fertilizers). To see pictures of quinine, click here.
Traditional Uses:* for malaria; as a bitter digestive aid to stimulate digestive juices; for nocturnal leg cramps; for intestinal parasites and protozoa; for arrhythmia and other heart conditions
For more information about quinine (Cinchona succirubra), please refer to the Database File for Quinine in the Tropical Plant Database. For general information on Raintree's available bulk plants and sustainable harvesting practices, please refer to Main Page for Bulk Plants.
This bulk one pound package retails for $28.00.
Purchase Quinine Powder Now
Print a PDF Quinine Powder Brochure
Ingredients: 100% pure quinine (Cinchona succirubra) bark. No binders, fillers or additives are used. It is a wild harvested product—grown naturally in the Brazilian Amazon without any pesticides or fertilizers.
Suggested Use: This plant is best prepared as a decoction. Use ½ teaspoon of powder for each cup of water. Bring to a boil and gently boil in a covered pot for 20 minutes. Allow to cool and settle for 10 minutes and strain warm liquid into a cup (leaving the settled powder in the bottom of the pan). It is traditionally taken in ½ cup dosages, 1-3 times daily. For more complete instructions on preparing herbal decoctions, see the Methods for Preparing Herbal Remedies Page.
Contraindications: Quinine bark contains naturally-occurring quinine alkaloids. These quinine alkaloids are sold as prescription drugs with numerous side effects and warnings documented in the literature. Do not exceed the suggested use shown above unless you are under the care and advice of a qualified health care practitioner who is familiar with the warnings, side effects, and contraindications of higher therapeutic levels of quinine alkaloids.
Drug Interactions: May potentiate blood thinning medications such as Warfarin®.
RELATED PRODUCTS:
Quinine can be found in these proprietary Raintree formulas:
Third-Party Published Research*
This Raintree product has not been the subject of any clinical research.All available third-party research on quinine can be found at PubMed.
A partial listing of the published research on quinine is shown below:
Anti-Parasitic & Antimalarial Actions:
Kumura, N., et al. “Synthesis and biological activity of fatty acid derivatives of quinine.” Biosci. Biotechnol. Biochem.
2005; 69(11): 2250-3.
Bertani, S., et al. “Evaluation of French Guiana traditional antimalarial remedies.” J. Ethnopharmacol. 2005 Apr
8; 98(1-2): 45-54.
Kanda, E., et al. “A female patient with malarial nephropathy.” Clin. Exp. Nephrol. 2004 Dec; 8(4): 359-62.
Pukrittayakamee, S., et al. “Quinine pharmacokinetic-pharmacodynamic relationships in uncomplicated falciparum
malaria.” Antimicrob. Agents Chemother. 2003; 47(11): 3458-63.
Warhurst, D. C., et al. “The relationship of physico-chemical properties and structure to the differential
antiplasmodial activity of the cinchona alkaloids.” Malar. J. 2003 Sep 1; 2: 26.
Pussard, E., et al. “Quinine distribution in mice with Plasmodium berghei malaria.” Eur. J. Drug Metab.
Pharmacokinet. 2003 Jan-Mar; 28(1): 11-20.
Vieira, J. L., et al. “Drug monitoring of quinine in men with nonsevere falciparum malaria: study in the Amazon
region of Brazil.” Ther. Drug Monit. 2001 Dec; 23(6): 612-5.
Aviado, D. M., et al. "Antimalarial and antiarrhythmic activity of plant extracts." Medicina
Experimentalis—International Journal of Experimental Medicine 1969; 19(20), 79–94.
Bitter Digestive Actions:
Yeomans, M. R. "Olfactory influences on appetite and satiety in humans." Physiol. Behav. 2006 Aug; 89(1): 10-4.
Kozlov, A. P., et al. “Taste differentiation in the context of suckling and independent, adultlike ingestive behavior.”
Dev. Psychobiol. 2006 Mar; 48(2): 133-45.
Dinehart, M. E., et al. “Bitter taste markers explain variability in vegetable sweetness, bitterness, and intake.”
Physiol. Behav. 2006; 87(2): 304-13.
Anti-cramping Actions:
Woodfield. R., et al. “N-of-1 trials of quinine efficacy in skeletal muscle cramps of the leg.” Br. J. Gen. Pract. 2005
Mar; 55(512): 181-5.
Diener, H. C., et al. "Effectiveness of quinine in treating muscle cramps: a double-blind, placebo-controlled, parallel-group, multicentre trial." Int. J. Clin. Pract. 2002; 56(4): 243–46.
Man-Son-Hing, M., et al. "Quinine for nocturnal leg cramps: a meta-analysis including unpublished data." J. Gen.
Intern. Med. 1998; 13(9): 600–6.
Antimicrobial Actions:
Rojas, J. J., et al. “Screening for antimicrobial activity of ten medicinal plants used in Colombian folkloric medicine:
A possible alternative in the treatment of non-nosocomial infections.” BMC Complement. Altern. Med. 2006 Feb
17; 6(1): 2.
Wolf, R., et al. “Quinine sulfate and HSV replication.” Dermatol. Online J. 2003 Aug; 9(3): 3.
Neuroprotective Actions:
Gigout, S., et al. “Effects of gap junction blockers on human neocortical synchronization.” Neurobiol. Dis. 2006 Jun; 22(3): 496-508.
Actions on Insulin Sensitivity:
Rustenbeck, I., et al. "Desensitization of insulin secretion by depolarizing insulin secretagogues." Diabetes. 2004 Dec; 53 Suppl 3: S140-50.
Grosse-Lackmann, T., et al. "Specificity of nonadrenergic imidazoline binding sites in insulin-secreting cells and relation to the block of ATP-sensitive K(+) channels." Ann. N. Y. Acad. Sci. 2003 Dec; 1009: 371-7.
Rustenbeck, I., et al. "Desensitization of insulin secretory response to imidazolines, tolbutamide, and quinine. II. Electrophysiological and fluorimetric studies." Biochem. Pharmacol. 2001 Dec; 62(12): 1695-703.
Rustenbeck, I., et al. "Desensitization of insulin secretory response to imidazolines, tolbutamide, and quinine. I. Secretory and morphological studies." Biochem. Pharmacol. 2001 Dec; 62(12): 1685-94.
Limburg, P.J., et al. "Quinine-induced hypoglycemia." Ann. Intern. Med. 1993 Aug; 119(3): 218-9.
MAO Actions:
Itoh, K., et al. “Stereospecific oxidation of the (S)-enantiomer of RS-8359, a selective and reversible monoamine
oxidase A (MAO-A) inhibitor, by aldehyde oxidase.” Xenobiotica. 2005; 35(6): 561-73.
Itoh, K., et al. “Species differences in enantioselective 2-oxidations of RS-8359, a selective and reversible MAO-A
inhibitor, and cinchona alkaloids by aldehyde oxidase.” Biopharm. Drug Dispos. 2006 Jan 6;27(3):133-139
Quinine Toxicity:
Flanagan, K. L., et al. “Quinine levels revisited: the value of routine drug level monitoring for those on parenteral
therapy.” Acta. Trop. 2006; 97(2): 233-7.
Osinubi, A. A., “Morphometric and stereological assessment of the effects of long-term administration of quinine
on the morphology of rat testis.” West Afr. J. Med. 2005 Jul-Sep; 24(3): 200-5.
Adam, I., et al. “Quinine for chloroquine-resistant falciparum malaria in pregnant Sudanese women in the first
trimester.” East Mediterr. Health J. 2004 Jul-Sep; 10(4-5): 560-5.
Adam, I., et al. “Low-dose quinine for treatment of chloroquine-resistant falciparum malaria in Sudanese pregnant
women.” East Mediterr. Health J. 2004 Jul-Sep; 10(4-5): 554-9.
Gopal, K. V., et al. “Unique responses of auditory cortex networks in vitro to low concentrations of quinine.”
Hear. Res. 2004 Jun; 192(1-2): 10-22.
Morrison, L. D., et al. “Death by quinine.” Vet. Hum. Toxicol. 2003 Dec; 45(6): 303-6.
Langford, N. J., et al. “Quinine intoxications reported to the Scottish Poisons Information Bureau 1997-2002: a
continuing problem.” Br. J. Clin. Pharmacol. 2003 Nov; 56(5): 576-8.
|
* The statements contained herein have not been evaluated
by the Food and Drug Administration.
This product is
not intended to treat, cure, mitigate or prevent any disease.
Please refer to our Conditions of Use for this web site and product.
Thank you for your support and
for choosing a Raintree Nutrition product!
Raintree Nutrition, Inc.
3579 Hwy 50 East, Suite 222
Carson City, NV 89701
(800) 780-5902
(775) 841-4142
(775) 841-4022 Fax
Return to Main Product Page
    
© Copyrighted 1996
to present by Raintree Nutrition, Inc., Carson City, NV 89701. All rights reserved.
Please read the Conditions of Use, Copyright Statement and our Privacy Policy for this web page and web site.
Last updated 3-20-2010
|